ALX Oncology

Contributing Author

Recent Articles by ALX Oncology

Oct-30	ALX Oncology to Report Third Quarter 2025 Financial Results and Pipeline Progress Including Evorpacept CD47 Biomarker Data to be Presented at Upcoming SITC Annual Meeting ALXO GlobeNewswire
Oct-23	ALX Oncology Announces Preclinical Data and Phase 1 Trial-in-Progress Presentations of ALX2004, a Novel EGFR-Targeted ADC, at 2025 AACR-NCI-EORTC Conference ALXO GlobeNewswire
Oct-03	ALX Oncology to Present Updated Data from Phase 2 ASPEN-06 Trial, Highlighting CD47 Expression as a Predictive Biomarker in HER2+ Gastric Cancer, at 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting ALXO GlobeNewswire
Sep-12	ALX Oncology Appoints Board Member Barbara Klencke, M.D., as Interim Chief Medical Officer ALXO GlobeNewswire
Aug-29	ALX Oncology to Participate in Upcoming Investor Conferences in September ALXO GlobeNewswire
Aug-19	ALX Oncology Doses First Patient in Phase 1 Dose Escalation Trial Evaluating ADC ALX2004 for the Treatment of EGFR-Expressing Solid Tumors ALXO GlobeNewswire
Aug-12	ALX Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update ALXO GlobeNewswire
Aug-05	ALX Oncology to Report Second Quarter 2025 Financial Results on August 12, 2025 ALXO GlobeNewswire
May-30	ALX Oncology to Present at the Jefferies 2025 Global Healthcare Conference ALXO GlobeNewswire
May-20	ALX Oncology Highlights Differentiated Design, Preclinical Data and Development Plans for EGFR-Targeted ADC, ALX2004, in R&D Webcast Event ALXO GlobeNewswire
May-13	ALX Oncology to Host R&D Webcast Event Highlighting its Novel EGFR Targeting Antibody-Drug Conjugate, ALX2004, on May 20, 2025 ALXO GlobeNewswire
May-08	ALX Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update ALXO GlobeNewswire
May-02	ALX Oncology to Report First Quarter 2025 Financial Results on May 8, 2025 ALXO GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.